These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21393169)

  • 1. Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection.
    Secher T; Fauconnier L; Szade A; Rutschi O; Fas SC; Ryffel B; Rudolf MP
    J Antimicrob Chemother; 2011 May; 66(5):1100-9. PubMed ID: 21393169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia.
    Que YA; Lazar H; Wolff M; François B; Laterre PF; Mercier E; Garbino J; Pagani JL; Revelly JP; Mus E; Perez A; Tamm M; Rouby JJ; Lu Q; Chastre J; Eggimann P
    Eur J Clin Microbiol Infect Dis; 2014 Oct; 33(10):1861-7. PubMed ID: 24859907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11.
    Horn MP; Zuercher AW; Imboden MA; Rudolf MP; Lazar H; Wu H; Hoiby N; Fas SC; Lang AB
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2338-44. PubMed ID: 20308370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative characterization of dipentameric (IgM)(2) and pentameric IgM species present in preparations of a monoclonal IgM for therapeutic use.
    Tarköy M; Wyss M; Rudolf MP
    J Pharm Biomed Anal; 2010 Apr; 51(5):1084-90. PubMed ID: 20005064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia.
    Lu Q; Rouby JJ; Laterre PF; Eggimann P; Dugard A; Giamarellos-Bourboulis EJ; Mercier E; Garbino J; Luyt CE; Chastre J; Georgescu-Kyburz V; Rudolf MP; Gafner V; Lazar H; Koch H; Perez A; Krämer SD; Tamm M
    J Antimicrob Chemother; 2011 May; 66(5):1110-6. PubMed ID: 21398296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early production of IL-17 protects against acute pulmonary Pseudomonas aeruginosa infection in mice.
    Liu J; Feng Y; Yang K; Li Q; Ye L; Han L; Wan H
    FEMS Immunol Med Microbiol; 2011 Mar; 61(2):179-88. PubMed ID: 21204996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa.
    van Gennip M; Moser C; Christensen LD; Bjarnsholt T; Calum H; Jensen PØ; Christophersen L; Hougen HP; Ciofu O; Molin S; Givskov M; Høiby N
    J Antimicrob Chemother; 2009 Dec; 64(6):1241-50. PubMed ID: 19815632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa.
    Schreiber JR; Patawaran M; Tosi M; Lennon J; Pier GB
    J Immunol; 1990 Feb; 144(3):1023-9. PubMed ID: 2104908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains.
    Pier GB; Boyer D; Preston M; Coleman FT; Llosa N; Mueschenborn-Koglin S; Theilacker C; Goldenberg H; Uchin J; Priebe GP; Grout M; Posner M; Cavacini L
    J Immunol; 2004 Nov; 173(9):5671-8. PubMed ID: 15494518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human monoclonal antibody that protects mice against Pseudomonas-induced pneumonia.
    Zweerink HJ; Detolla LJ; Gammon MC; Hutchison CF; Puckett JM; Sigal NH
    J Infect Dis; 1990 Jul; 162(1):254-7. PubMed ID: 2113078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-Pseudomonas aeruginosa antibody Panobacumab is efficacious on acute pneumonia in neutropenic mice and has additive effects with meropenem.
    Secher T; Fas S; Fauconnier L; Mathieu M; Rutschi O; Ryffel B; Rudolf M
    PLoS One; 2013; 8(9):e73396. PubMed ID: 24023870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of doripenem in the treatment of Pseudomonas aeruginosa experimental pneumonia versus imipenem and meropenem.
    Bretonnière C; Jacqueline C; Caillon J; Guitton C; Le Mabecque V; Miégeville AF; Villers D; Potel G; Boutoille D
    J Antimicrob Chemother; 2010 Nov; 65(11):2423-7. PubMed ID: 20858688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
    Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K
    J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV.
    Frank DW; Vallis A; Wiener-Kronish JP; Roy-Burman A; Spack EG; Mullaney BP; Megdoud M; Marks JD; Fritz R; Sawa T
    J Infect Dis; 2002 Jul; 186(1):64-73. PubMed ID: 12089663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.
    Lang AB; Fürer E; Senyk G; Larrick JW; Cryz SJ
    Hum Antibodies Hybridomas; 1990; 1(2):96-103. PubMed ID: 2129420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa. Vaccines and immunotherapy.
    Pennington JE
    Infect Dis Clin North Am; 1990 Jun; 4(2):259-70. PubMed ID: 2111838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Pseudomonas aeruginosa IgY antibodies augment bacterial clearance in a murine pneumonia model.
    Thomsen K; Christophersen L; Bjarnsholt T; Jensen PØ; Moser C; Høiby N
    J Cyst Fibros; 2016 Mar; 15(2):171-8. PubMed ID: 26303991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
    Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
    Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In a murine model of acute lung infection, airway administration of a therapeutic antibody confers greater protection than parenteral administration.
    Sécher T; Dalonneau E; Ferreira M; Parent C; Azzopardi N; Paintaud G; Si-Tahar M; Heuzé-Vourc'h N
    J Control Release; 2019 Jun; 303():24-33. PubMed ID: 30981816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.